Home Business Chinas Property Crisis Grinds On and Continues to Hold Back the Economy

Chinas Property Crisis Grinds On and Continues to Hold Back the Economy

Share
chinas-property-crisis-grinds-on-and-continues-to-hold-back-the-economy
Chinas Property Crisis Grinds On and Continues to Hold Back the Economy
Share

The property crisis that began in 2021 has had a long, ugly tail that seems to get ever longer.Construction workers leave a building site for a new office tower in the Central Business District in Beijing on April 3, 2025. Kevin Frayer/Getty Images1/23/2026|Updated: 1/23/2026CommentaryChina’s by now infamous property crisis is entering its fifth year. It continues to weigh on the country’s economy, holding back homebuilding, consumer spending, and investments in business expansion and modernization.Milton Ezrati is a contributing editor at The National Interest, an affiliate of the Center for the Study of Human Capital at the University at Buffalo (SUNY), and chief economist for Vested, a New York-based communications firm. Before joining Vested, he served as chief market strategist and economist for Lord, Abbett & Co. He also writes frequently for City Journal and blogs regularly for Forbes. His latest book is “Thirty Tomorrows: The Next Three Decades of Globalization, Demographics, and How We Will Live.”Author’s Selected Articles

Share
Related Articles
usda-unveils-new-support-for-ranchers-to-rebuild-cattle-herds
BusinessEconomyUSUS News

USDA Unveils New Support for Ranchers to Rebuild Cattle Herds

The U.S. Department of Agriculture has unveiled a new package of measures...

how-major-us-stock-indexes-fared-aug.-31
BrightBusinessInvestingMarketsPersonal FinanceStocks

How Major US Stock Indexes Fared Aug. 31

Oil prices rose and U.S. stocks fell after American forces struck Iranian...

trump-unveils-new-drug-pricing-deals-with-9-pharmaceutical-companies
BusinessCompaniesExecutive BranchUSUS NewsUS Politics

Trump Unveils New Drug Pricing Deals With 9 Pharmaceutical Companies

President Donald Trump on Aug. 31 announced agreements with nine midsize pharmaceutical...